Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: Metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours

Journal of Pathology

Volumn 201, Issue 3, 2003, Pages 439-450

  Peng, Dun Fa ^a   Sugihara, Hiroyuki ^a   Mukaisho, Ken Ichi ^a   Tsubosa, Yasuhiro ^a   Hattori, Takanori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Array CGH; CGH; Diffuse type gastric cancer; DOP PCR; Laser microdissection

Indexed keywords

OLIGONUCLEOTIDE;

ADULT; AGED; AMPLICON; ARTICLE; CANCER GROWTH; CANCER STAGING; CHROMOSOME 10Q; CHROMOSOME 12P; CHROMOSOME 12Q; CHROMOSOME 15Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME MICRODISSECTION; CHROMOSOME NUMBER; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DNA MICROARRAY; FEMALE; FREQUENCY ANALYSIS; GENE LOCUS; GENETIC STABILITY; HUMAN; HUMAN TISSUE; MALE; METAPHASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE DELETION; HUMANS; HYBRIDIZATION, GENETIC; LASER SURGERY; LYMPHATIC METASTASIS; MALE; MICRODISSECTION; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 0242558946     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1459     Document Type: Article

References (50)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841.
2. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31-49.
3. Sugihara H, Hattori T, Fujita S, Fukuda M. Regional ploidy variations in signet ring cell carcinomas of the stomach. Cancer 1990: 65: 122-129.
4. Hattori T, Sugihara H, Fukuda M, Hamada S, Fujita S. DNA ploidy patterns of minute carcinomas in the stomach. Jpn J Cancer Res 1986; 77: 276-281.
5. Ochi H, Douglass HOJ, Sandberg AA. Cytogenetic studies in primary gastric cancer. Cancer Genet Cytogenet 1986; 22: 295-307.
6. Seruca R, Castedo S, Correia C, Gomes P, et al. Cytogenetic findings in eleven gastric carcinomas. Cancer Genet Cytogenet 1993; 68: 42-48.
7. Kallioniemi A, Kallioniemi O-P, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
8. Speicher MR, du Manoir S, Schröck E, et al. Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 1993; 2: 1907-1914.
9. James LA. Comparative genomic hybridization as a tool in tumor cytogenetics. J Pathol 1999; 187: 385-395.
10. Knuutila S, Björkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 1107-1123.
11. Knuutila S, Aalto Y, Autio K, et al. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155: 683-694.
12. Kokkola A, Monni O, Puolakkainen P, et al. 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 1997; 20: 38-43.
13. Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F, Lichter P. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998; 23: 307-316.
14. Sakakura C, Mori T, Sakabe T, et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 24: 299-305.
15. Guan XY, Fu SB, Xia JC, et al. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet Cytogenet 2000; 123: 27-34.
16. Koo SH, Kwon KC, Shin SY, et al. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence in situ hybridization studies. Cancer Genet Cytogenet 2000; 117: 97-103.
17. Noguchi T, Wirtz HC, Michaelis S. Gabbert HE, Mueller W. Chromosomal imbalances in gastric cancer: correlation with histologic subtypes and tumor progression. Am J Clin Pathol 2001; 115: 828-834.
18. Kong G, Oga A, Park CK, Kawauchi S, Furuya T, Sasaki K. DNA sequence copy number aberrations associated with histological subtypes and DNA ploidy in gastric carcinoma. Jpn J Cancer Res 2001; 92: 740-747.
19. Wu CW, Chen GD. Fann CSJ, et al. Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes Chromosomes Cancer 2002; 35: 219-231.
20. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23-28.
21. Telenius H, Carter NP, Bebb CE, et al. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992; 13: 718-725.
22. Kallioniemi O-P, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994; 10: 231-243.
23. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarray. Nature Genet 1998; 20: 207-211.
24. Pollack JR, Perou CM, Alizadeh AA, et al. Genomic-wide analysis of DNA copy number changes using cDNA microarray. Nature Genet 1999; 23: 41-46.
25. Daigo Y, Chin SF, Gorringe KL, et al. Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers. Am J Pathol 2001; 158: 1623-1631.
26. Sugihara H, Hattori T, Fukuda M, Katsura K, Fujita S. Progression of signet ring cell carcinomas in the human stomach. Cancer 1993; 71: 1938-1947.
27. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma (First English edn). Kanehara: Tokyo, 1995.
28. Tokugawa T, Sugihara H, Tani T, Hattori T. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 2002: 62: 4938-4944.
29. Kamitani S, Sugihara H, Shiomi H, Tani T, Hattori T. Intratumoral regional variations in copy number of the chromosomal part revealed by microdissection and combined ploidy and comparative genomic hybridization analyses in esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2002; 132: 30-35.
30. Okada K, Sugihara H, Bamba M, Bamba T, Hattori T. Sequential numerical changes of chromosomes 7 and 18 in diffuse-type stomach cancer cell lines: combined comparative genomic hybridization, fluorescence in situ hybridization, and ploidy analysis. Cancer Genet Cytogenet 2000; 118: 99-107.
31. Varis A, Wolf M, Monni O, et al. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 2002; 62: 2625-2629.
32. Sugimoto N, Imoto I, Fukuda Y, et al. IQGAP1, a negative regulator of cell-cell adhesion, is upregulated by gene amplification at 15q26 in gastric cancer cell lines HSC39 and 40A. J Hum Genet 2001; 46: 21-25.
33. Yokoi S, Yasui K, Saito-Ohara F, et al. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol 2002; 161: 207-216.
34. Nowell PC. Chromosomal and molecular clues to tumor progression. Semin Oncol 1989; 16: 116-127.
35. Fujita S. Biology of early gastric carcinoma. Pathol Res Proct 1978; 163: 297-309.
36. Heidenblad M, Jonson T, Mahlamaki EH, et al. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification. Genes Chromosomes Cancer 2002; 34: 211-223.
37. Tsujimoto H, Sugihara H, Hagiwara A, Hattori T. Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer. Virchows Arch 1997; 431: 383-389.
38. Gunther T, Schneider-Stock R, Hackel C, et al. MDM2 gene amplification in gastric cancer correlation with expression of mdm2 protein and p53 alteration. Mod Pathol 2000; 13: 621-626.
39. Woenckhaus J, Steger K, Werner E, et al. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 2002; 198: 335-342.
40. Byun DS, Cho K, Ryu BK, et al. Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma. Int J Cancer 2003(104): 318-327.
41. Armengol G, Knuutila S, Lluis F, et al. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma. Cancer Genet Cytogenet 2000; 116: 133-141.
42. Hara T, Ooi A, Kobayashi M, et al. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Lab Invest 1998; 78: 1143-1153.
43. Hughes SJ, Glover TW, Zhu XX, et al. A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc Natl Acad Sci U S A 1998; 95: 12 410-12 415.
44. Shinomiya T, Mori T, Ariyama Y, et al. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DP1 gene in the 13q34 amplicon. Genes Chromosomes Cancer 1999; 24: 337-344.
45. Koyama K, Fukushima Y, Inazawa J, et al. The human homologue of the murine Llglh gene (LLGL) maps within the Smith-Magenis syndrome region in 17p11.2. Cytogenet Cell Genet 1996; 72: 78-82.
46. Bignell GR, Warren W, Seal S, et al. Identification of the familial cylindromatosis tumor-suppressor gene. Nature Genet 2000; 25: 160-165.
47. Richard FM, McKee SA, Rajpar MH, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999; 8: 607-610.
48. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nature Genet 2000; 26: 16-17.
49. Ascano JJ, Frierson H, Moskaluk CA, et al. Inactivation of the E-cadherin gene in sporadic diffuse type gastric cancer. Mod Pathol 2001; 14: 942-949.
50. Tamura G, Sato K, Akiyama S, et al. Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 2001; 81: 593-598.